Galectin Therapeutics Inc.GALTNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank43
3Y CAGR-27.5%
5Y CAGR-20.5%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-27.5%/yr
vs +89.8%/yr prior
5Y CAGR
-20.5%/yr
Recent deceleration
Acceleration
-117.3pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $15.12M | -41.1% |
| 2023 | $25.66M | +38.0% |
| 2022 | $18.59M | -53.1% |
| 2021 | $39.65M | +46.1% |
| 2020 | $27.14M | -42.8% |
| 2019 | $47.48M | +475.3% |
| 2018 | $8.25M | +170.3% |
| 2017 | $3.05M | -80.1% |
| 2016 | $15.36M | -40.6% |
| 2015 | $25.85M | - |